MACC1 and neoplasm: Cores with representative tumor material and evaluable staining were available in 266 of 360 samples (73.9%), with 211 samples (79.3%) being MACC1-positive (samples with IRS > 5) and 55 samples (20.7%) being MACC1-negative (samples with IRS < 5) (Figure 1).